BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today announced the pricing of its underwritten public offering of 2,700,000 shares of its 7.50% Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (“Series A Preferred Stock”), raising net proceeds of approximately $65.2 million, after deducting underwriting discounts and commissions and estimated offering expenses. The Series A Preferred Stock has an initial liquidation preference of $25.00 per share. The offering is expected to close on September 15, 2017, subject to customary closing conditions. The Company has granted the underwriters a 30-day option to purchase up to an additional 405,000 shares of Series A Preferred Stock at the public offering price to cover over-allotments, if any. The Company intends to apply to list the Series A Preferred Stock on the New York Stock Exchange under the symbol "GMRE PrA." If the application is approved, the Company expects trading to commence 30 days after initial delivery of the Series A Preferred Stock.
The Company intends to use the net proceeds from this offering for general corporate purposes, which may include funding new acquisitions, and repaying indebtedness.
FBR Capital Markets & Co., a B. Riley Financial Company, and Janney Montgomery Scott are serving as the book-running managers for the offering. BB&T Capital Markets, Compass Point and D.A. Davidson & Co. are serving as co-managers.
The offering is being made pursuant to the Company’s shelf registration statement, which was declared effective by the U.S. Securities and Exchange Commission (“SEC”) on June 19, 2017. Copies of the preliminary prospectus supplement and accompanying prospectus may be obtained from the SEC’s website at www.sec.gov or by contacting: FBR Capital Markets & Co., 1300 North 17th Street, Suite 1400, Arlington, Virginia 22209 or by email at firstname.lastname@example.org.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these shares or any other securities in any state in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any state.
About Global Medical REIT Inc.
Global Medical REIT Inc. is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company intends to produce increasing, reliable rental revenue by expanding its portfolio, and leasing each of its healthcare facilities to market-leading operators under a long-term triple-net lease. The Company’s management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers. The Company intends to elect to be taxed as a REIT for U.S. federal income tax purposes, commencing with its taxable year ended December 31, 2016.
This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements, including, without limitation, the satisfaction of all conditions to, and the timely closing of, the offering. These forward-looking statements may include, but are not limited to, the timing of the closing of the offering and the amount and intended use of the net proceeds. These risks and uncertainties are described in greater detail in the Company’s filings with the SEC, including, without limitation, the Company’s annual and periodic reports and other documents filed with the SEC. Unless legally required, the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The Company undertakes no obligation to update these statements after the date of this release.